Diffuse Bio develops an automated AI software platform for drug design, leveraging advances in generative AI.
Diffuse Bio has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2023.
Diffuse Bio's investors include Y Combinator, Fellows Fund.
Diffuse Bio is headquartered in San Francisco, United States.
Diffuse Bio develops an automated AI software platform for drug design, leveraging advances in generative AI.
Diffuse Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Diffuse Bio — Funding & Investors." VCBacked, April 5, 2023, https://www.vcbacked.co/company/diffuse-bio. Accessed September 30, 2026.
VCBacked. (2023). Diffuse Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/diffuse-bio
{{cite web |title=Diffuse Bio — Funding & Investors |url=https://www.vcbacked.co/company/diffuse-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated